NovoCure Limited Operating Lease, Liability, Noncurrent
NovoCure Limited (NVCR) had Operating Lease, Liability, Noncurrent of $37.53 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-07-23
- 2026-06-30: Operating Lease, Liability, Noncurrent $37.53M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $39.48M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $41.65M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $42.68M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $37.53M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $39.48M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $41.65M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $42.68M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $42.85M 10-Q · filed 2025-07-24 |
| 2025-03-31 | $40.31M 10-Q · filed 2025-04-24 |
| 2024-12-31 | $19.97M 10-K · filed 2026-02-26 |
| 2024-09-30 | $21.14M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $21.73M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $25.61M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $27.42M 10-K · filed 2025-02-27 |
| 2023-09-30 | $22.05M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $20.33M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $19.97M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $18.76M 10-K · filed 2024-02-22 |
| 2022-09-30 | $14.83M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $13.38M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $14.81M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $13.00M 10-K · filed 2023-02-23 |
| 2021-09-30 | $11.48M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $11.94M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $12.71M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $14.29M 10-K · filed 2022-02-24 |
| 2020-09-30 | $13.08M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $13.67M 10-Q/A · filed 2020-10-02 |
| 2020-03-31 | $13.27M 10-Q/A · filed 2020-10-02 |
| 2019-12-31 | $14.14M 10-K · filed 2021-02-25 |
| 2019-09-30 | $11.37M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $11.58M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $11.02M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $0.00 10-Q · filed 2019-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |